IDRA - Idera Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue16,19924973
Cost of Revenue---
Gross Profit16,19924973
Operating Expenses
Research Development39,82433,69927,493
Selling General and Administrative15,13215,39611,332
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-38,757-48,846-38,752
Income from Continuing Operations
Total Other Income/Expenses Net448396137
Earnings Before Interest and Taxes-38,309-48,450-38,615
Interest Expense8010527
Income Before Tax-38,389-48,555-38,642
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-38,389-48,555-38,642
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-38,389-48,555-38,642
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-38,389-48,555-39,161